CIS is First to Use Auryon XL Radial Access Catheter

Lodha First Auryon XL

LAFAYETTE, LA– Cardiovascular Institute of the South (CIS) is the first to use FDA-cleared Auryon XL Radial Access Catheter by Angiodynamics, Inc. to treat peripheral artery disease (PAD), or blockages in the legs. The procedure was performed by CIS interventional cardiologist, Dr. Ankur Lodha, at the CIS office-based lab in Lafayette. 

The Auryon XL Catheter, available in 0.9 mm and 1.5 mm diameters, expands treatment access points in atherectomy procedures for PAD. It is used with the Auryon Atherectomy System.

"Radial access is more than an entry point; it's a transformative expressway to enhanced patient outcomes,” said Dr. Lodha. “With an innovative design and its ease-of-use, the Auryon XL Catheter brings significant advancements to radial procedures as the first non-orbital atherectomy device – setting a new standard for laser atherectomy technology.”

Peripheral artery disease, or PAD, occurs when plaque buildup causes the arteries of the legs to narrow, constricting blood flow. Symptoms include leg swelling, pain, cramping, discoloration, or ulcers. If you think you may have PAD, schedule an appointment with a CIS cardiologist near you.



Latest News

CIS Staff

Written by CIS Staff